Copenhagen-based Ventriject, a MedTech startup behind expertise that precisely measures cardiorespiratory health (CRF), has simply closed a €1.7 million funding spherical following growth into a number of European markets.
The spherical, led by primarily by present buyers, builds on earlier raises in 2021 and 2024. Traders embody the Export and Funding Fund of Denmark (EIFO), TechStation | HardTech Innovation Hub, Investo Capital, and personal investor, Carsten Stendevad, a former CEO of one of many largest pension funds in Denmark.
CEO Mikkel Kristiansen shared with EU-Startups: “We’re extremely pleased with the continued nice belief now we have from our present buyers, in addition to from the brand new buyers who’ve come on board. There was a variety of curiosity in us as an organization over the previous yr – from potential prospects, companions, and buyers alike. Now we have created a product that actually resonates with the time we’re in, the place there’s an elevated deal with preventative well being and on dwelling more healthy and longer.
“We are able to see this in our European markets, and we’re additionally experiencing nice curiosity from the American market. Subsequently, the following interval will likely be actually thrilling for us as an organization, and this capital injection will assist us intensify the journey we’re on proper now.”
VentriJect is a spinout from Aalborg College in Denmark, and regardless of being based in 2018, the corporate already had a finalised product prepared for commercialisation by 2021. Their expertise reportedly has each medical and health purposes, which has enabled the corporate to increase quickly throughout the EU since its first bigger increase in 2021.
The flagship machine, the Seisomofit, is a CE-marked medical machine that makes use of a expertise known as seismocardiography to measure actions within the chest wall brought on by beating coronary heart vibrations.
With the Seismofit system, an individual’s cardiorespiratory health (quantified as VO2 max) might be estimated in lower than 3 minutes with out the usage of train. Utilising this along with the VentriJect algorithm, an outline of the VO2max is delivered through the VentriJect app to the consumer.
Anders Throup-Jensen from EIFO mentioned “We’re more than happy to have invested in VentriJect’s newest funding spherical. Now we have been an investor within the firm since 2021 and consider in a robust future for the corporate as a market chief in VO2 Max measurements. Now we have been very impressed by the staff and their means to open new markets. I sit up for persevering with to work with the administration staff as we develop our gross sales within the EU and the US.”
CEO Kristiansen sees VentriJect benefiting from a wider growth within the Nordic startup scene. He says that though Denmark is effectively recognised as a manufacturing unit for modern tech startups, there may be rising curiosity in healthtech particularly. He cites the funding of €48 million by Novo Holdings and the Export and Funding Fund of Denmark (EIFO) into the HealthCap IX fund centered on Nordic HealthTech as only one instance of how VC funding waking as much as the medical expertise alternatives within the area.
The startup says they’ve prospects in a number of European markets, and has not too long ago signed distributors in Denmark, the Netherlands, Sweden, Switzerland, and the UK.
They’re additionally in remaining negotiations with a number of healthcare suppliers throughout Europe. VentriJect can be exploring US market entry. This would supply entry to over 55,000 well being golf equipment and the world’s largest healthcare market.
